CLINICAL_TRIALS
trial_result
· 2019-12-20
Clinical Trial Update: A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Summary
Phase 3 trial update of erlotinib in locally advanced or metastatic non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-12-20